Nodal/Activin Signaling Drives Self-Renewal and Tumorigenicity of Pancreatic Cancer Stem Cells and Provides a Target for Combined Drug Therapy

Bailey, 2008, Sonic hedgehog promotes desmoplasia in pancreatic cancer, Clin. Cancer Res., 14, 5995, 10.1158/1078-0432.CCR-08-0291

Bar, 2007, Cyclopamine-mediated hedgehog pathway inhibition depletes stem-like cancer cells in glioblastoma, Stem Cells, 25, 2524, 10.1634/stemcells.2007-0166

Borovski, 2011, Cancer Stem Cell Niche: The Place to Be, Cancer Research, 71, 634, 10.1158/0008-5472.CAN-10-3220

Engelmann, 2008, MCF7 side population cells with characteristics of cancer stem/progenitor cells express the tumor antigen MUC1, Cancer Res., 68, 2419, 10.1158/0008-5472.CAN-07-2249

Friess, 1994, Cripto, a member of the epidermal growth factor family, is over-expressed in human pancreatic cancer and chronic pancreatitis, Int. J. Cancer, 56, 668, 10.1002/ijc.2910560511

Gallmeier, 2011, Inhibition of ATR Function Abrogates the in Vitro and in Vivo Tumorigenicity of Human Colon Cancer Cells Through Depletion of the CD133+ Tumor-Initiating Cell Fraction, Stem Cells, 29, 418, 10.1002/stem.595

Heddleston, 2009, The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype, Cell Cycle, 8, 3274, 10.4161/cc.8.20.9701

Hendrix, 2007, Reprogramming metastatic tumour cells with embryonic microenvironments, Nat. Rev. Cancer, 7, 246, 10.1038/nrc2108

Hermann, 2007, Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer, Cell Stem Cell, 1, 313, 10.1016/j.stem.2007.06.002

Hermann, 2008, Metastatic cancer stem cells: a new target for anti-cancer therapy?, Cell Cycle, 7, 188, 10.4161/cc.7.2.5326

Jesnowski, 2005, Immortalization of pancreatic stellate cells as an in vitro model of pancreatic fibrosis: deactivation is induced by matrigel and N-acetylcysteine, Lab. Invest., 85, 1276, 10.1038/labinvest.3700329

Jones, 2008, Core signaling pathways in human pancreatic cancers revealed by global genomic analyses, Science, 321, 1801, 10.1126/science.1164368

Kleeff, 1998, Concomitant over-expression of activin/inhibin beta subunits and their receptors in human pancreatic cancer, Int. J. Cancer, 77, 860, 10.1002/(SICI)1097-0215(19980911)77:6<860::AID-IJC11>3.0.CO;2-5

Li, 2007, Identification of pancreatic cancer stem cells, Cancer Res., 67, 1030, 10.1158/0008-5472.CAN-06-2030

Massagué, 2008, TGFbeta in Cancer, Cell, 134, 215, 10.1016/j.cell.2008.07.001

Meyer, 2009, Dynamic regulation of CD24 and the invasive, CD44posCD24neg phenotype in breast cancer cell lines, Breast Cancer Res., 11, R82, 10.1186/bcr2449

Mueller, 2009, Combined targeted treatment to eliminate tumorigenic cancer stem cells in human pancreatic cancer, Gastroenterology, 137, 1102, 10.1053/j.gastro.2009.05.053

Neesse, 2010, Stromal biology and therapy in pancreatic cancer, Gut, 60, 861, 10.1136/gut.2010.226092

Ohnishi, 2003, Activin A is an autocrine activator of rat pancreatic stellate cells: potential therapeutic role of follistatin for pancreatic fibrosis, Gut, 52, 1487, 10.1136/gut.52.10.1487

Olive, 2009, Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer, Science, 324, 1457, 10.1126/science.1171362

Omary, 2007, The pancreatic stellate cell: a star on the rise in pancreatic diseases, J. Clin. Invest., 117, 50, 10.1172/JCI30082

Piccirillo, 2006, Bone morphogenetic proteins regulate tumorigenicity in human glioblastoma stem cells, Ernst Schering Found. Symp. Proc., 2006, 59

Postovit, 2008, Human embryonic stem cell microenvironment suppresses the tumorigenic phenotype of aggressive cancer cells, Proc. Natl. Acad. Sci. USA, 105, 4329, 10.1073/pnas.0800467105

Rubio-Viqueira, 2006, An in vivo platform for translational drug development in pancreatic cancer, Clin. Cancer Res., 12, 4652, 10.1158/1078-0432.CCR-06-0113

Scaffidi, 2011, In vitro generation of human cells with cancer stem cell properties, Nat. Cell Biol., 13, 1051, 10.1038/ncb2308

Schneider, 2003, Genetic alterations in pancreatic carcinoma, Mol. Cancer, 2, 15, 10.1186/1476-4598-2-15

Shimizu, 2008, Mechanisms of pancreatic fibrosis and applications to the treatment of chronic pancreatitis, J. Gastroenterol., 43, 823, 10.1007/s00535-008-2249-7

Shinozaki, 2008, Indian hedgehog promotes the migration of rat activated pancreatic stellate cells by increasing membrane type-1 matrix metalloproteinase on the plasma membrane, J. Cell. Physiol., 216, 38, 10.1002/jcp.21372

Strizzi, 2005, Cripto-1: a multifunctional modulator during embryogenesis and oncogenesis, Oncogene, 24, 5731, 10.1038/sj.onc.1208918

Topczewska, 2006, Embryonic and tumorigenic pathways converge via Nodal signaling: role in melanoma aggressiveness, Nat. Med., 12, 925, 10.1038/nm1448

Torres, 2011, Non-integrative lentivirus drives high-frequency cre-mediated cassette exchange in human cells, PLoS ONE, 6, e19794, 10.1371/journal.pone.0019794

Vallier, 2005, Activin/Nodal and FGF pathways cooperate to maintain pluripotency of human embryonic stem cells, J. Cell Sci., 118, 4495, 10.1242/jcs.02553

Watabe, 2009, Roles of TGF-beta family signaling in stem cell renewal and differentiation, Cell Res., 19, 103, 10.1038/cr.2008.323

Xiao, 2006, Activin A maintains self-renewal and regulates fibroblast growth factor, Wnt, and bone morphogenic protein pathways in human embryonic stem cells, Stem Cells, 24, 1476, 10.1634/stemcells.2005-0299

Yoshinaga, 2004, N-cadherin is regulated by activin A and associated with tumor aggressiveness in esophageal carcinoma, Clin. Cancer Res., 10, 5702, 10.1158/1078-0432.CCR-03-0262

Yoshinaga, 2008, Activin a causes cancer cell aggressiveness in esophageal squamous cell carcinoma cells, Ann. Surg. Oncol., 15, 96, 10.1245/s10434-007-9631-1

Zhang, 2009, Non-Smad pathways in TGF-beta signaling, Cell Res., 19, 128, 10.1038/cr.2008.328